Diagnosis of MCADD
Diagnosis of MCADD (Medium-chain acyl-CoA dehydrogenase deficiency) is essential for preventing serious health complications, particularly in infants and young children.
Early testing helps families and doctors take action before a crisis happens. Since the signs can appear suddenly and may look like common illnesses, fast and correct testing is key. Today, thanks to newborn screening programs, many children are diagnosed before they even show symptoms.
Newborn Screening and Early Detection
The most common way to make a diagnosis of MCADD is through newborn screening. This test happens within the first 24 to 48 hours after birth.
A small blood sample is taken from the baby’s heel and placed on a filter paper card, often called a Guthrie card. This sample is tested using tandem mass spectrometry. This advanced tool looks for high levels of certain fat-related markers, especially octanoylcarnitine (C8). High C8 levels can signal MCADD and trigger further tests.
Confirming the Diagnosis
When screening shows a possible problem, doctors run confirmatory tests. These tests give a clearer picture and confirm whether the child really has MCADD.
One of the key follow-up tests is a blood acylcarnitine profile. It shows the levels of different fat-related compounds. In MCADD, the C6, C8, and C10 markers are usually high, with C8 being the highest.
A urine test may also be done. It looks for dicarboxylic acids like suberic acid, which go up when fat metabolism is blocked. These acids are higher during times of stress or illness.
Genetic Testing for MCADD
Another important step in the diagnosis of MCADD is genetic testing. When the biochemical signs are present, doctors check the ACADM gene for changes.
This gene controls the enzyme needed to break down certain fats. The most common mutation, especially in people of Northern European background, is called K304E.
Finding the mutation confirms the diagnosis. It also helps with future planning. Parents and siblings can be tested to see if they carry the gene.
Diagnosis Without Newborn Screening
In some places, newborn screening may not be available. Or a child might show symptoms before results come back. In these cases, doctors usually find MCADD during or after a health crisis.
The child may come to the hospital with low blood sugar but no ketones in the urine or blood. Normally, the body makes ketones during fasting. But in MCADD, this doesn’t happen. This unusual pattern—called non-ketotic hypoglycaemia—is a major warning sign.
Extra tests then look at fat-related markers in the blood and acids in the urine. If these match MCADD, doctors confirm the diagnosis with a genetic test.
Mild or Late-Onset Cases
Sometimes, older kids or even adults get tested after repeated tiredness, poor fasting ability, or low blood sugar. These signs may not be easy to link to MCADD at first.
In rare cases, doctors may use a fasting test to see how the body reacts. But this is risky and not done often. Instead, safer tests like the acylcarnitine profile and DNA analysis are used.
Some people carry the gene but never show symptoms. They may have mild changes in their blood markers, which can confuse the picture. That’s why a specialist in metabolism should always review the results.
A correct diagnosis of MCADD must include symptoms, lab results, and genetic findings. This avoids mistakes in diagnosis or unnecessary treatment.
Importance of Early Diagnosis
Early detection has changed everything. When MCADD is found through newborn screening and managed well, almost all major problems can be avoided.
This shows how powerful newborn testing can be. It saves lives and helps children grow up healthy.
Summary: How Diagnosis of MCADD Is Made
In conclusion, diagnosis of MCADD usually starts with newborn screening using tandem mass spectrometry. If results show high levels of certain markers, follow-up blood and urine tests confirm the findings.
A genetic test then verifies the condition by finding changes in the ACADM gene. When these steps happen early, doctors can start treatment right away.
Thanks to this process, many children now live full, healthy lives without serious complications. The diagnosis of MCADD has become a key part of modern infant care.
